Research News From August 23, 2017
advertisement
- Reprogramming human gallbladder cells into insulin-producing β-like cells. Free full text available in HTML and PDF formats.
- Efficacy and safety of Biosimilar (SAR342434 insulin lispro) in adults with type 1 diabetes also using insulin glargine-SORELLA 1 study. Free full text available in PDF format. See also Biosimilar of Humalog Shows Non-Inferiority in Type 1 Diabetes.
- Attenuated Suppression of Lipolysis Explains Increases in Triglyceride Secretion and Concentration with Basal Insulin Peglispro (BIL) Relative to Insulin Glargine Treatment in Patients with Type 1 Diabetes.
- Single Dose Euglycemic Clamp Studies Demonstrating Pharmacokinetic and Pharmacodynamic Similarity Between MK-1293 Insulin Glargine and Originator Insulin Glargine (Lantus) in Type 1 Diabetes and Healthy Subjects.
- Detection of Islet Cell Immune Reactivity with Low Glycemic Index Foods: Is This a Concern for Type 1 Diabetes? Free full text available in HTML and PDF formats.
